← Browse by Condition
Medical Condition
leukemia myeloid acute
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 2
NCT06956755
Recruiting
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Enrollment
6,990 pts
Location
France
Sponsor
Groupe Francophone des Myelody...
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
Enrollment
120 pts
Location
United States, Canad...
Sponsor
OncoVerity, Inc.
NCT06785077
Recruiting
Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors
Enrollment
157 pts
Location
Italy
Sponsor
European Institute of Oncology
NCT05270200 Phase 1, Phase 2
Recruiting
Single Arm Study of Post-transplant Azacitidine and Chidamide for Prevention of Acute Myelogenous Leukemia Relapse
Enrollment
20 pts
Location
China
Sponsor
Zhujiang Hospital
NCT06852222 Phase 3
Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment
600 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...